The companies that bet the most on innovation: amount spent on research and development during the fiscal year 2010.
| # | Enterprise | Market | Sector | R&D expenses (USD) |
|---|---|---|---|---|
| 1 | 🇺🇸United States | Healthcare | 22 134 billion $ | |
| 2 | 🇨🇭Europe | Healthcare | 12,22 billion $10,03 Bn CHF | |
| 3 | 🇺🇸United States | Healthcare | 11,11 billion $ | |
| 4 | 🇺🇸United States | Healthcare | 9,36 billion $ | |
| 5 | 🇨🇭Europe | Healthcare | 9,07 billion $ | |
| 6 | 🇺🇸United States | Technology | 8,71 billion $ | |
| 7 | 🇩🇪Germany | Consumer Cyclical | 7,65 billion $6,87 Md€ | |
| 8 | 🇺🇸United States | Healthcare | 6,84 billion $ | |
| 9 | 🇰🇷Korea | Technology | 6,67 billion $9 099 Md₩ | |
| 10 | 🇺🇸United States | Technology | 6,58 billion $ | |
| 11 | 🇫🇮Europe | Technology | 6,54 billion $5,86 Md€ | |
| 12 | 🇺🇸United States | Technology | 6,03 billion $ | |
| 13 | 🇬🇧United Kingdom | Healthcare | 5,75 billion $4,30 Bn£ | |
| 14 | 🇺🇸United States | Technology | 5,27 billion $ | |
| 15 | 🇫🇷France | Healthcare | 4,91 billion $4,40 Md€ | |
| 16 | 🇺🇸United States | Healthcare | 4,88 billion $ | |
| 17 | 🇯🇵Japan | Consumer Cyclical | 4,58 billion $725,35 Bn¥ | |
| 18 | 🇺🇸United States | Industrials | 4,12 billion $ | |
| 19 | 🇬🇧United Kingdom | Healthcare | 4,10 billion $ | |
| 20 | 🇩🇪Germany | Industrials | 3,97 billion $3,56 Md€ | |
| 21 | 🇩🇪Germany | Consumer Cyclical | 3,88 billion $3,48 Md€ | |
| 22 | 🇺🇸United States | Technology | 3,76 billion $ | |
| 23 | 🇺🇸United States | Healthcare | 3,57 billion $ | |
| 24 | 🇺🇸United States | Healthcare | 3,57 billion $ | |
| 25 | 🇩🇪Germany | Consumer Cyclical | 3,44 billion $3,08 Md€ | |
| 26 | 🇩🇪Germany | Healthcare | 3,40 billion $3,05 Md€ | |
| 27 | 🇳🇱Europe | Industrials | 3,28 billion $2,94 Md€ | |
| 28 | 🇺🇸United States | Technology | 3,25 billion $ | |
| 29 | 🇸🇪Europe | Technology | 3,19 billion $31,56 billion SEK | |
| 30 | 🇺🇸United States | Technology | 2,96 billion $ | |
| 31 | 🇯🇵Japan | Consumer Cyclical | 2,92 billion $463,35 Bn¥ | |
| 32 | 🇺🇸United States | Healthcare | 2,89 billion $ | |
| 33 | 🇺🇸United States | Healthcare | 2,81 billion $ | |
| 34 | 🇯🇵Japan | Technology | 2,73 billion $432,00 Bn¥ | |
| 35 | 🇺🇸United States | Technology | 2,55 billion $ | |
| 36 | 🇯🇵Japan | Industrials | 2,49 billion $395,18 Bn¥ | |
| 37 | 🇳🇱Europe | Technology | 2,35 billion $ | |
| 38 | 🇫🇷France | Consumer Cyclical | 2,04 billion $1,83 Md€ | |
| 39 | 🇯🇵Japan | Technology | 1,99 billion $315,82 Bn¥ | |
| 40 | 🇩🇪Germany | Technology | 1,93 billion $1,73 Md€ | |
| 41 | 🇺🇸United States | Industrials | 1,91 billion $ | |
| 42 | 🇯🇵Japan | Healthcare | 1,82 billion $288,87 Bn¥ | |
| 43 | 🇺🇸United States | Technology | 1,78 billion $ | |
| 44 | 🇳🇱Europe | Healthcare | 1,76 billion $1,58 Md€ | |
| 45 | 🇯🇵Japan | Communication Services | 1,76 billion $278,14 Bn¥ | |
| 46 | 🇺🇸United States | Industrials | 1,75 billion $ | |
| 47 | 🇺🇸United States | Technology | 1,74 billion $275,97 Bn¥ | |
| 48 | 🇺🇸United States | Consumer Cyclical | 1,73 billion $ | |
| 49 | 🇬🇧United Kingdom | Industrials | 1,73 billion $1,30 Bn£ | |
| 50 | 🇨🇭Europe | Consumer Defensive | 1,71 billion $1,40 Bn CHF | |
| 51 | 🇩🇪Germany | Basic Materials | 1,66 billion $1,49 Md€ | |
| 52 | 🇺🇸United States | Basic Materials | 1,66 billion $ | |
| 53 | 🇩🇪Germany | Consumer Cyclical | 1,62 billion $1,45 Md€ | |
| 54 | 🇳🇱Europe | Consumer Cyclical | 1,60 billion $1,43 Md€ | |
| 55 | 🇺🇸United States | Technology | 1,57 billion $ | |
| 56 | 🇩🇪Germany | Healthcare | 1,56 billion $1,40 Md€ | |
| 57 | 🇮🇪Europe | Healthcare | 1,46 billion $ | |
| 58 | 🇺🇸United States | Industrials | 1,45 billion $ | |
| 59 | 🇺🇸United States | Industrials | 1,43 billion $ | |
| 60 | 🇩🇰Europe | Healthcare | 1,43 billion $9,60 Bn DKK | |
| 61 | 🇯🇵Japan | Technology | 1,42 billion $224,95 Bn¥ | |
| 62 | 🇺🇸United States | Technology | 1,41 billion $ | |
| 63 | 🇺🇸United States | Communication Services | 1,34 billion $ | |
| 64 | 🇨🇳China | Industrials | 1,32 billion $8,82 billion CN¥ | |
| 65 | 🇸🇪Europe | Industrials | 1,31 billion $12,97 billion SEK | |
| 66 | 🇯🇵Japan | Technology | 1,28 billion $202,62 Bn¥ | |
| 67 | 🇺🇸United States | Healthcare | 1,25 billion $ | |
| 68 | 🇯🇵Japan | Healthcare | 1,24 billion $196,80 Bn¥ | |
| 69 | 🇯🇵Japan | Healthcare | 1,23 billion $195,57 Bn¥ | |
| 70 | 🇹🇼Taiwan | Technology | 1,18 billion $38,79 Bn NT$ | |
| 71 | 🇺🇸United States | Technology | 1,14 billion $ | |
| 72 | 🇳🇱Europe | Consumer Cyclical | 1,13 billion $1,01 Md€ | |
| 73 | 🇺🇸United States | Industrials | 1,11 billion $175,12 Bn¥ | |
| 74 | 🇰🇷Korea | Technology | 1,10 billion $1 501 Md₩ | |
| 75 | 🇨🇭Europe | Industrials | 1,08 billion $ | |
| 76 | 🇺🇸United States | Healthcare | 1,07 billion $ | |
| 77 | 🇨🇳China | Technology | 1,06 billion $7,09 billion CN¥ | |
| 78 | 🇺🇸United States | Industrials | 1,05 billion $ | |
| 79 | 🇺🇸United States | Healthcare | 1,04 billion $164,51 Bn¥ | |
| 80 | 🇺🇸United States | Technology | 1,04 billion $ | |
| 81 | 🇬🇧United Kingdom | Consumer Defensive | 1,03 billion $928,0 M€ | |
| 82 | 🇬🇧United Kingdom | Energy | 1,02 billion $ | |
| 83 | 🇧🇷Others | Energy | 989,0 M$ | |
| 84 | 🇨🇦Canada | Technology | 965,0 M$ | |
| 85 | 🇺🇸United States | Healthcare | 939,0 M$ | |
| 86 | 🇮🇱Others | Healthcare | 933,0 M$ | |
| 87 | 🇺🇸United States | Energy | 919,0 M$ | |
| 88 | 🇺🇸United States | Healthcare | 915,0 M$ | |
| 89 | 🇺🇸United States | Technology | 908,9 M$ | |
| 90 | 🇺🇸United States | Consumer Cyclical | 908,0 M$ | |
| 91 | 🇹🇼Taiwan | Technology | 906,3 M$29,71 Bn NT$ | |
| 92 | 🇧🇷Others | Basic Materials | 878,0 M$ | |
| 93 | 🇮🇪Europe | Technology | 877,0 M$ | |
| 94 | 🇺🇸United States | Technology | 857,0 M$ | |
| 95 | 🇺🇸United States | Technology | 828,2 M$ | |
| 96 | 🇺🇸United States | Healthcare | 809,5 M$ | |
| 97 | 🇧🇪Europe | Healthcare | 786,0 M$705,0 M€ | |
| 98 | 🇬🇧United Kingdom | Energy | 781,3 M$ | |
| 99 | 🇺🇸United States | Technology | 781,0 M$ | |
| 100 | 🇯🇵Japan | Industrials | 775,7 M$122,90 Bn¥ |
⚠ Ranking provided for information purposes, based on public data. It does not constitute investment advice. Values may contain source errors and change with financial publications.